September 18-20, 2017
Ocean Place Resort, Long Branch, NJ

> 2017 Exhibitors

> 2016 Exhibitors

> 2014 Exhibitors

Download Exhibitor Manual

Download Exhibitor Electric Form

ChemOutsourcing Banner To Alert Contacts You’re Attending

2017 Exhibitor List

read: buyers and suppliers together

Exhibitor List As Of May 28, 2017

Look for exhibitors according to their first letter.

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Show All

 

Daikin America, Inc.
DavosPharma
Domainex
Dottikon

Daikin America, Inc. [ company website ]

For almost a century, since 1924, Daikin has been a world leader in the development, manufacture and sales of fluoropolymers, fluoroelastomers, fluorochemicals, and fluorocoatings. Headquartered in Osaka, Japan, Daikin is renowned for innovation, quality products and customer commitment. With manufacturing, sales, and technical support located in 9 countries throughout the world and with over 36,000 employees in North America, South America, Europe and Asia, Daikin has a strong global foundation.

DavosPharma [ company website ]

We provide custom chemistry (novel raw materials, GMP intermediates, regulatory starting materials & APIs) and custom dosage forms (parenterals and orals), with supporting development, analytics, stability and regulatory documentation. We have successfully leveraged thirty-seven years of custom manufacturing experience, forming global strategic alliances with well-vetted, cGMP custom manufacturers in the EU, North America and Asia. Our expertise enables us to match your particular need with the supplier best able to deliver your project. Davos shares your risk by billing for deliverables, not best efforts, providing an additional level of assurance and oversight between you and the supplier.

Domainex [ company website ]

Domainex is a fully integrated drug discovery service company based near Cambridge, UK serving pharmaceutical, biotechnology, academic and patient foundations globally. Domainex provides highly efficient and well considered scientific solutions to enable successful drug discovery programmes against a wide range of targets. Our highly experienced molecular biologists, medicinal, computation and analytical chemists have a strong success record in drug discovery, delivering on average one candidate drug every year for the past six years.

Dottikon [ company website ]

DOTTIKON EXCLUSIVE SYNTHESIS is specialized on hazardous chemistry, with a focus on strongly exothermic reactions as well as unstable, highly reactive, or high-potent compounds or mixtures. DOTTIKON ES manufactures high-quality intermediates and exclusive APIs, from the kilogram to the multi-ton range, for the world's leading pharmaceutical and chemical industries. Hazardous reactions often allow to shorten production and synthesic procedures, reduce waste, improve yields, selectivity, and purity, and therefore reduce overall costs. Among the core strengths of DOTTIKON ES are: hazardous reactions, such as reductions with complex hydrides, alkylations, azide chemistry, nitrations and oxidations. As well as heterogeneous and homogeneous catalytic hydrogenations, continuous reaction technologies and low temperature reactions.